Based on the findings from other IF staining outcomes, CSP, SSa, and NGN administration resulted in elevated levels of CD206 (an M2 marker) compared to the NASH group; conversely, the expression of CD68 (an M1 marker) was lower (Figure 3b,c). The gene discussed is CD68; the disease is metabolic dysfunction-associated steatohepatitis.